160
Participants
Start Date
July 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Nateglinide 120 mg
Nateglinide 120 mg was supplied as tablets.
Acarbose 50 mg
Acarbose 50 mg was supplied as tablets.
People's Liberation Army. The Military General Hospital of BeiJing, Beijing
Peiking University First Hospital, Beijing
Chinese PLA General Hospital, Beijing
The First Affiliated Hospital, Zhongshan (Sun Yat-sen) University, Guangzhou
The Second Affiliated Hospital, Zhongshan (Sun Yat-sen) University, Guangzhou
Nanfang Hospital, the Affiliated South Hospital of the Southern Medical University, Guangzhou
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY